The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Is there a withdrawal syndrome with abiraterone acetate (AA)?
Laurence Albiges
No relevant relationships to disclose
Edouard Auclin
No relevant relationships to disclose
Benoit Rousseau
No relevant relationships to disclose
Elouen Boughalem
No relevant relationships to disclose
Antonin Levy
No relevant relationships to disclose
Yohann Loriot
No relevant relationships to disclose
Mario Di Palma
No relevant relationships to disclose
Christophe Massard
Consultant or Advisory Role - Janssen Pharmaceutical
Karim Fizazi
Consultant or Advisory Role - Janssen Pharmaceutical